SSSovan Samanta

Sovan Samanta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sovan Samanta has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Nutritional anthropometric indices and dietary profile of fishermen at coastal region of Purba Medinipur district, India: A cross-sectional study

    by Sk Nazibar Rahaman, Swarnali Das, Sovan Samanta, Rubai Ahmed, Jhimli Banerjee, Priyajit Chatterjee, Kazi Monjur Ali, Amitava Pal, Sandeep Kumar Dash

    Background: The physical performance of any occupation depends on an individual’s nutrition and health, which is directly linked to good dietary practices. The objective of the present study is to explore the impact of diet and nutrient consumption on the nutritional status of fishermen. Methods: A cross-sectional study was conducted on 410 fishermen and 51 non-fishermen aged 25–60 years in the selected coast of Purba (East) Medinipur district, West Bengal. Anthropometric measurements and a diet survey were carried out using a standard protocol. Data analysis was done using statistical software. Results: The prevalence of overweight and obese fishermen in the present study is 21.46% and 28.29%. Correlation analysis suggested that there is a significant association of different anthropometric variables like body mass index, mid upper arm circumference, Waist circumference, Hip circumference, waist hip ratio, Body fat (%), Fat weight, and Lean body mass with calorie, protein, fat, and carbohydrate intake in both fishermen and non-fishermen. Conclusion: Based on results, it is concluded that energy, protein, vitamin C, and fat consumption are higher in fishermen than in non-fishermen, whereas iron consumption is lower in both participants compared to the recommended dietary allowance (2010). Statistical analysis indicated that the number of overweight and obese fishermen was significantly ( p < 0.000) high.

  • Enhancing Immunological Memory: Unveiling Booster Doses to Bolster Vaccine Efficacy Against Evolving SARS-CoV-2 Mutant Variants

    by Sovan Samanta, Jhimli Banerjee, Aparna Das, Sourav Das, Rubai Ahmed, Swarnali Das, Amitava Pal, Kazi Monjur Ali, Rupanjan Mukhopadhyay, Biplab Giri, et al.

    A growing number of re-infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in previously immunized individuals has sparked discussions about the potential need for a booster vaccine dosage to counteract declining antibody levels and new strains. The protective immunity produced by vaccinations, and past illnesses relies on immunological memory. CD4 + T cells, CD8 + T cells, B cells, and long-lasting antibody responses are all components of the adaptive immune system that can generate and maintain this immunological memory. Since novel mutant variants have emerged one after the other, the world has been hit by repeated waves. Various vaccine formulations against SARS-CoV-2 have been administered across the globe. Thus, estimating the efficacy of those vaccines against gradually developed mutant stains is the essential parameter regarding the fate of those vaccine formulations and the necessity of booster doses and their frequency. In this review, focus has also been given to how vaccination stacks up against moderate and severe acute infections in terms of the longevity of the immune cells, neutralizing antibody responses, etc. However, hybrid immunity shows a greater accuracy of re-infection of variants of concern (VOCs) of SARS-CoV-2 than infection and immunization. The review conveys knowledge of detailed information about several marketed vaccines and the status of their efficacy against specific mutant strains of SARS-CoV-2. Furthermore, this review discusses the status of immunological memory after infection, mixed infection, and vaccination.


  • XBB and BQ.1, the two Omicron cousins dominating globally: Is it the time we should think again?

    by Rubai Ahmed, Sovan Samanta, Jhimli Banerjee, Sandeep Kumar Dash

  • Bioactive Pentacyclic Triterpenes Trigger Multiple Signalling Pathways for Selective Apoptosis Leading to Anticancer Efficacy: Recent Updates and Future Perspectives

    by Jhimli Banerjee, Sovan Samanta, Rubai Ahmed, Sandeep Kumar Dash

    Nowadays, discovering an effective and safe anticancer medication is one of the major challenges. Premature death due to the unidirectional toxicity of conventional therapy is common in cancer patients with poor health status. Plants have been used as medicine since prehistoric times, and extensive research on the anticancer properties of various bioactive phytomolecules is ongoing. Pentacyclic triterpenoids are secondary metabolites of plants with well-known cytotoxic and chemopreventive properties established in numerous cancer research studies. The lupane, oleanane, and ursane groups of these triterpenoids have been well-studied in recent decades for their potential antitumor activity. This review delves into the molecular machinery governing plant-derived triterpenes' anticancer efficacy. The highlighted mechanisms are antiproliferative activity, induction of apoptosis through regulation of BCL-2 and BH3 family proteins, modulation of the inflammatory pathway, interference with cell invagination and inhibition of metastasis. Lack of solubility in mostly used biological solvents is the major barrier to the therapeutic progress of these triterpenoids. This review also highlights some probable ways to mitigate this issue with the help of nanotechnology and the modification of their physical forms.


  • Open Access

    Tomato flu: A mysterious catastrophic infection knocking at the door

    by Sovan Msc Samanta, Jhimli Msc Banerjee, Swarnali Msc Das, Rubai Msc Ahmed, Sandeep Kumar Dash

  • Self-Assembled Maslinic Acid Attenuates Doxorobucin Induced Cytotoxicity via Nrf2 Signaling Pathway: An In Vitro and In Silico Study in Human Healthy Cells

    by Jhimli Banerjee, Sk Nurul Hasan, Sovan Samanta, Biplab Giri, Braja Gopal Bag, Sandeep Kumar Dash

    The clinical applications of some well-known chemotherapeutic drugs for cancer treatment have been restricted nowadays owing to their adverse effects on many physiological systems. In this experimental study, maslinic acid (MA) isolated from Olea europaea (Olive) fruit extract was used to mitigate the cytotoxicity induced by Doxorubicin (DOX) in human healthy peripheral blood mononuclear cells (hPBMCs). Self-assembled maslinic acid (SA-MA) was obtained in ethanol-water mixture (35.5 mM: 4:1 v/v). The morphology of SA-MA was analyzed by various physicochemical characterization techniques, which revealed its micro-metric vesicular architecture as well as nano-vesicular appearances. In this study, treatment of hPBMCs with DOX has been found to generate severe intracellular oxidative stress, which was significantly mitigated after pre-treatment with SA-MA. Alteration of hPBMC morphologies after DOX treatment was also restored notably by pre-treatment with SA-MA. Furthermore, pentoxifylline (TNF-α inhibitor) and indomethacin (COX-2 inhibitor) were used to investigate the responsible pathway by which SA-MA protected hPBMCs from DOX-induced cellular stress. Restoration of hPBMC viability above 92% in both cases confirmed that SA-MA protected the cells by inhibiting inflammatory pathways generated by DOX treatment. Subsequently, in molecular docking study, it was also evaluated that MA could successfully bind with the pocket region of Keap1, while Nrf2 was capable of upregulating cytoprotecting genes.